Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buccal Infiltration plus Inferior Alveolar Nerve Block vs Inferior Alveolar Nerve Block Alone in Mandibular Molars with Irreversible Pulpitis
TCTR20250923005Phase 1Completed
- Sponsor
- Fatima Jinnah Dental College
- Start
- Oct 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of ropivacaine in irreversible pulpitis (2 arms), sponsored by Fatima Jinnah Dental College. Primary endpoint: Anesthetic efficacy during treatment. Started Oct 2022; status: completed.
02
Drugs
ropivacaine
03
Conditions
irreversible pulpitis
Beyond the preview
Go deeper on TCTR20250923005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250923005.